Skip to main content
Year archive

Leadway Technology Investment Group Limited — 2021 filings

All 88 regulatory filings released by Leadway Technology Investment Group Limited (2086) in 2021, sourced directly from the official regulator.

88 Filings
2021 Period
2021 filings (88)
Filing Released Lang
List of Directors and their Roles and Functions
Board/Management Information
2021-12-22 English
Change of Directors
Board/Management Information
2021-12-22 English
Poll Results of the Extraordinary General Meeting held on 22 December 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-22 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-12-10 English
Notice of Extraordinary General Meeting
AGM Information
2021-12-02 English
Form of Proxy for Extraordinary General Meeting to be held on 22 December 2021
Proxy Solicitation & Information Statement
2021-12-02 English
Renewal of Existing Connected Transactions, Entering Into of New Continuing Connected Transactions and Notice of Extraordinary General Meeting
Regulatory Filings
2021-12-02 English
Renewal of Existing Continuing Connected Transactions, Entering Into of New Continuing Connected Transactions and Notice of Extraordinary General Meeting
Proxy Solicitation & Information Statement
2021-12-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2021
Regulatory Filings
2021-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-01 English
Renewal of Existing Continuing Connected Transactions and Entering Into of New Continuing Connected Transactions
Regulatory Filings
2021-11-17 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
Regulatory Filings
2021-11-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2021
Regulatory Filings
2021-11-02 English
ANNOUNCEMENT ON THE COURT RULING OF SANCTION OF THE REORGANISATION PLAN OF INDIRECT CONTROLLING SHAREHOLDER
Regulatory Filings
2021-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings
2021-11-01 English
Unaudited Financial Results for the nine months ended 30 September 2021 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report
2021-10-25 English
INSIDE INFORMATION ANNOUNCEMENT ON POLL RESULTS OF THE SECOND CREDITORS' MEETING ON THE REORGANISATION OF INDIRECT CONTROLLING SHAREHOLDER
Regulatory Filings
2021-10-24 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-10-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2021
Regulatory Filings
2021-10-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Regulatory Filings
2021-10-05 English
Major and Connected Transaction - Disposal of 78.45% Equity Interest in Tianjin Tianduan Press Co., Ltd.
Proxy Solicitation & Information Statement
2021-09-23 English
2021 Interim Report
Interim / Quarterly Report
2021-09-17 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-09-10 English
Interim Report 2021
Interim / Quarterly Report
2021-09-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2021
Regulatory Filings
2021-09-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Regulatory Filings
2021-09-01 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021
Interim / Quarterly Report
2021-08-30 English
Interim Dividend for the six months ended 30 June 2021
Notice of Dividend Amount
2021-08-30 English
Announcement of Interim Results for the six months ended 30 June 2021
Interim / Quarterly Report
2021-08-30 English
Major and Connected Transaction - Disposal of 78.45% Equity Interest in Tianjin Tianduan Press Co., Ltd.
M&A Activity
2021-08-26 English
Unaudited Financial Results for the six months ended 30 June 2021 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report
2021-08-24 English
Positive Profit Alert
Regulatory Filings
2021-08-20 English
Date of Board Meeting
Regulatory Filings
2021-08-18 English
NOTICE OF BOARD MEETING
Regulatory Filings
2021-08-11 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
Regulatory Filings
2021-08-11 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2021-08-11 English
CHANGES IN DIRECTORSHIP AND MEMBERS OF REMUNERATION COMMITTEE
Board/Management Information
2021-08-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2021
Regulatory Filings
2021-08-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-02 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-07-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2021
Share Issue/Capital Change
2021-07-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021
Share Issue/Capital Change
2021-07-05 English
Poll Results of the Annual General Meeting held on 24 June 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-24 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-06-11 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2021-06-04 English
RESIGNATION OF NON-EXECUTIVE DIRECTOR
Board/Management Information
2021-06-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2021
Share Issue/Capital Change
2021-06-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021
Share Issue/Capital Change
2021-06-01 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 25 MAY 2021
Declaration of Voting Results & Voting Rights Announcements
2021-05-25 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-05-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2021
Capital/Financing Update
2021-05-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Share Issue/Capital Change
2021-05-03 English
Completion of Change of Shareholding Structure of Intermediate Controlling Shareholder of the Company and Continuing Connected Transactions
Regulatory Filings
2021-04-30 English
Unaudited Financial Results for the three months ended 31 March 2021 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report
2021-04-28 English
Notice of Annual General Meeting
AGM Information
2021-04-28 English
Form of Proxy for Annual General Meeting to be held on 24 June 2021
AGM Information
2021-04-28 English
General Mandates to Issue Shares and to Buy Back Shares, Re-election of Directors and Notice of Annual General Meeting
AGM Information
2021-04-28 English
Annual Report 2020
Annual Report
2021-04-28 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (or at any adjournment thereof)
AGM Information
2021-04-16 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-16 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-16 English
Annual Report 2020
Annual Report
2021-04-16 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-04-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021
Share Issue/Capital Change
2021-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Share Issue/Capital Change
2021-04-01 English
Announcement of Final Results for the year ended 31 December 2020
Annual Report
2021-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020
Annual Report
2021-03-24 English
Audited Financial Results for the year ended 31 December 2020 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Annual Report
2021-03-24 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROFIT WARNING
Regulatory Filings
2021-03-15 English
INSIDE INFORMATION ANNOUNCEMENT ON THE COURT RULING OF REORGANISATION OF INDIRECT CONTROLLING SHAREHOLDER
Regulatory Filings
2021-03-15 English
Date of Board Meeting
Regulatory Filings
2021-03-15 English
PROFIT WARNING
Regulatory Filings
2021-03-12 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-03-11 English
Profit Warning
Regulatory Filings
2021-03-10 English
NOTICE OF BOARD MEETING
Regulatory Filings
2021-03-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2021
Regulatory Filings
2021-03-03 English
CHANGE IN ADDRESS OF PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2021-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Share Issue/Capital Change
2021-03-01 English
Overseas Regulatory Announcement
Earnings Release
2021-02-26 English
ANNOUNCEMENT ON THE COURT RULING OF ACCEPTING THE REORGANISATION PETITION AGAINST INDIRECT CONTROLLING SHAREHOLDER
Legal Proceedings Report
2021-02-11 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-02-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2021
Regulatory Filings
2021-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Share Issue/Capital Change
2021-02-01 English
INSIDE INFORMATION ANNOUNCEMENT ON REORGANISATION PETITION AGAINST INDIRECT CONTROLLING SHAREHOLDER
Regulatory Filings
2021-01-31 English
Continuing Connected Transactions - Entrusted Processing Master Agreement
Regulatory Filings
2021-01-19 English
ANNOUNCEMENT MONTHLY PROGRESS UPDATE ON THE POSSIBLE TRANSACTION PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity
2021-01-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2020
Share Issue/Capital Change
2021-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Share Issue/Capital Change
2021-01-04 English